Evidence map›Paper›PMID 29881681›Full record

ArticleActa pharmaceutica Sinica. B2018

Nanoparticles with high payloads of pipemidic acid, a poorly soluble crystalline drug: drug-initiated polymerization and self-assembly approach.

Elisabetta Pancani, Mario Menendez-Miranda, Alexandra Pastor, François Brisset, Marie-Françoise Bernet-Camard, Didier Desmaële, Ruxandra Gref

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Lipid carriers for mRNA delivery.Acta pharmaceutica Sinica. B · 2023
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Elisabetta PancaniInstitut de Sciences Moléculaires d'Orsay (ISMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France.
Mario Menendez-MirandaInstitut de Sciences Moléculaires d'Orsay (ISMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France.
Alexandra PastorInstitut de Sciences Moléculaires d'Orsay (ISMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France.
François BrissetInstitut de Chimie Moléculaire et des Matériaux d'Orsay (ICMMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France.
Marie-Françoise Bernet-CamardEA4043 "Unité Bactéries Pathogènes et Santé" (UBaPS), Univ. of Paris-Sud, Université Paris-Saclay, Châtenay-Malabry 92290, France.
Didier DesmaëleInstitut Galien, UMR8612 Univ. of Paris-Sud, Université Paris-Saclay, Châtenay-Malabry 92290, France.
Ruxandra GrefInstitut de Sciences Moléculaires d'Orsay (ISMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France.
Université Paris-Saclay · FRUniversité Paris-Sud · FRInstitut de Chimie Moléculaire et des Matériaux d'Orsay · FRInstitut des Sciences Moléculaires d'Orsay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, biodegradable polymers such as poly(lactic acid) (PLA), poly(D,L-lactic-

Indexed as

AntibioticCrystalline drugDrug-initiated   polymerizationNanoparticleNanoprecipitationPipemidic acid

Identifiers

PMID29881681
PMCPMC5989915
OpenAlexW2794846647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.